Cancer Urology

Онкоурология

1726-97761996-1812

Publishing House ABV Press

205

10.17650/1726-9776-2009-5-1-56-63

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS

ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ

COMPLEX ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH ADVANCED AND LOCALLY ADVANCED PROSTATE CANCER

КОМПЛЕКСНЫЙ АНАЛИЗ ФАКТОРОВ ПРОГНОЗА У БОЛЬНЫХ ЛОКАЛИЗОВАННЫМ И МЕСТНО-РАСПРОСТРАНЕННЫМ РАКОМ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ

Vorobyev

N. V.

Воробьев

Н. В.

Russian Federation

Alekseyev

B. Ya.

Алексеев

Б. Я.

Russian Federation

Filimonov

V. V.

Филимонов

В. В.

Russian Federation

Zemlyansky

A. Yu.

Землянский

А. Ю.

Russian Federation

P.A. Herzen Moscow Research Oncological InstituteМНИОИ им. П.А. Герцена

Moscow State Institute of Experimental MedicineМГИЭМ

M.V. Lomonosov Moscow State UniversityМГУ им. М.В. Ломоносова

30032009

56630108201401082014

https://oncourology.abvpress.ru/oncur/article/view/205

Комплексный анализ факторов прогноза у больных локализованным и местно-распространенным раком предстательной железы

1. Greenlee R.T., Hill-Harmon M.B.,Murray T. et al. Cancer statistics, 2001. CACancer J Clin 2001;51:15—36.

Greenlee R.T., Hill-Harmon M.B.,Murray T. et al. Cancer statistics, 2001. CACancer J Clin 2001;51:15—36.

2. Чиссов В.И., Старинский В.В. Забо-леваемость злокачественными новооб-разованиями в России. М., 2007.

Чиссов В.И., Старинский В.В. Забо-леваемость злокачественными новооб-разованиями в России. М., 2007.

3. Матвеев Б.П. Клиническая онкоуро-логия. М., 2003.

Матвеев Б.П. Клиническая онкоуро-логия. М., 2003.

4. Лопаткин Н.А., Поповкин Н.Н., Зи-борова И.В. и др. К вопросу об эпиде-миологии рака предстательной железыв России. В сб.: Материалы Пленумаправления Российского общества уро-логов. Омск, 2003. с. 27—30.

Лопаткин Н.А., Поповкин Н.Н., Зи-борова И.В. и др. К вопросу об эпиде-миологии рака предстательной железыв России. В сб.: Материалы Пленумаправления Российского общества уро-логов. Омск, 2003. с. 27—30.

5. Велиев Е.И. Оптимизация хирурги-ческого лечения больных локализован-ным раком предстательной железы. Ав-тореф. дис. … докт. мед. наук. СПб.,2003.

Велиев Е.И. Оптимизация хирурги-ческого лечения больных локализован-ным раком предстательной железы. Ав-тореф. дис. … докт. мед. наук. СПб.,2003.

6. Пушкарь Д.Ю. Радикальная проста-тэктомия. М.; МЕДпресс-информ,2002.

Пушкарь Д.Ю. Радикальная проста-тэктомия. М.; МЕДпресс-информ,2002.

7. Переверзев А.С., Коган М.И. Ракпростаты. Харьков, 2004.

Переверзев А.С., Коган М.И. Ракпростаты. Харьков, 2004.

8. Wang L., Hricak H., Kattan M.W. et al.Combined endorectal and phased-arrayMRI in the prediction of pelvic lymphnode metastasis in prostate cancer. AJRAm J Roentgenol 2006;186(3):743—8.

Wang L., Hricak H., Kattan M.W. et al.Combined endorectal and phased-arrayMRI in the prediction of pelvic lymphnode metastasis in prostate cancer. AJRAm J Roentgenol 2006;186(3):743—8.

9. Levran Z., Gonzalez J.A., Diokno A.C.et al. Are pelvic computed tomography,bone scan and pelvic lymphadenectomynecessary in the staging of prostatic cancer?Br J Urol 1995;75(6):778—81.

Levran Z., Gonzalez J.A., Diokno A.C.et al. Are pelvic computed tomography,bone scan and pelvic lymphadenectomynecessary in the staging of prostatic cancer?Br J Urol 1995;75(6):778—81.

10.

10. Suarez P., Mondes L., Bernardo N. et al. Correlation between computed axialtomography and ileum obturating lym-phadenectomy in localized adenocarcino-ma of the prostate. Arch Esp Urol1997;50:131—3.

Suarez P., Mondes L., Bernardo N. et al. Correlation between computed axialtomography and ileum obturating lym-phadenectomy in localized adenocarcino-ma of the prostate. Arch Esp Urol1997;50:131—3.

11.

11. Ohori M., Kattan M.W., Koh H. et al.Predicting the presence and side of extra-capsular extension: a nomogram for stagingprostate cancer. J Urol 2004;171:1844—9.

Ohori M., Kattan M.W., Koh H. et al.Predicting the presence and side of extra-capsular extension: a nomogram for stagingprostate cancer. J Urol 2004;171:1844—9.

12.

12. Partin A.W., Carter H.B. The use ofprostate-specific antigen and free/totalprostate-specific antigen in the diagnosis oflocalized prostate cancer. Urol Clin NorthAm 1996;23(4):531—40.

Partin A.W., Carter H.B. The use ofprostate-specific antigen and free/totalprostate-specific antigen in the diagnosis oflocalized prostate cancer. Urol Clin NorthAm 1996;23(4):531—40.

13.

13. Partin A.W., Kattan M.W., Subong E.N.et al. Combination of prostate-specificantigen, clinical stage, and Gleason scoreto predict pathological stage of localizedprostate cancer. A multi-institutionalupdate. JAMA 1997;277(18):1445—51.

Partin A.W., Kattan M.W., Subong E.N.et al. Combination of prostate-specificantigen, clinical stage, and Gleason scoreto predict pathological stage of localizedprostate cancer. A multi-institutionalupdate. JAMA 1997;277(18):1445—51.

14.

14. Steuber T., Graefen M., Haese A. et al.Validation of a nomogram for prediction ofside specific extracapsular extension at rad-ical prostatectomy. J Urol 2006;175:939—44.

Steuber T., Graefen M., Haese A. et al.Validation of a nomogram for prediction ofside specific extracapsular extension at rad-ical prostatectomy. J Urol 2006;175:939—44.

15.

15. Koh H., Kattan M.W., Scardino P.T. et al. A nomogram to predict seminal vesi-cle invasion by the extent and location ofcancer in systematic biopsy results. J Urol2003;170:1203—8.

Koh H., Kattan M.W., Scardino P.T. et al. A nomogram to predict seminal vesi-cle invasion by the extent and location ofcancer in systematic biopsy results. J Urol2003;170:1203—8.

16.

16. Cagiannos I., Karakiewicz P., Eastham J.A. et al. A preoperative nomo-gram identifying decreased risk of positivepelvic lymph nodes in patients with prostatecancer. J Urol 2003;170:1798—803.

Cagiannos I., Karakiewicz P., Eastham J.A. et al. A preoperative nomo-gram identifying decreased risk of positivepelvic lymph nodes in patients with prostatecancer. J Urol 2003;170:1798—803.

17.

17. Briganti A., Chun F.K., Salonia A. et al. Validation of a nomogram predictingthe probability of lymph node invasionamong patients undergoing radical prostate-ctomy and an extended pelvic lym-phadenectomy. Eur Urol 2006;49:1019—27.

Briganti A., Chun F.K., Salonia A. et al. Validation of a nomogram predictingthe probability of lymph node invasionamong patients undergoing radical prostate-ctomy and an extended pelvic lym-phadenectomy. Eur Urol 2006;49:1019—27.

18.

18. Schwarzer G., Vach W., Schumacher M. On the misuses of artificialneural networks for prognostic and diag-nostic classification in oncology. Stat Med2000;19:541—61.

Schwarzer G., Vach W., Schumacher M. On the misuses of artificialneural networks for prognostic and diag-nostic classification in oncology. Stat Med2000;19:541—61.

19.

19. Karakiewicz P.I., Chun F.K., Briganti A. et al. Prostate cancer nomo-grams are superior to neural networks. CanJ Urol 2006;13:18—25.

Karakiewicz P.I., Chun F.K., Briganti A. et al. Prostate cancer nomo-grams are superior to neural networks. CanJ Urol 2006;13:18—25.

20.

20. Kattan M.W. Comparison of Coxregression with other methods for deter-mining prediction models and nomo-grams.J Urol 2003;170:6—9.

Kattan M.W. Comparison of Coxregression with other methods for deter-mining prediction models and nomo-grams.J Urol 2003;170:6—9.

21.

21. Kattan M.W. Nomograms.Introduction. Semin Urol Oncol2002;20:79—81.

Kattan M.W. Nomograms.Introduction. Semin Urol Oncol2002;20:79—81.

22.

22. Ross P.L., Scardino P.T., Kattan M.W.A catalog of prostate cancer nomograms. JUrol 2001;165:1562—8.

Ross P.L., Scardino P.T., Kattan M.W.A catalog of prostate cancer nomograms. JUrol 2001;165:1562—8.

23.

23. Kattan M.W., Eastham J.A., Stapleton A.M. et al. A preoperative nomo-gram for disease recurrence following radi-cal prostatectomy for prostate cancer. JNatl Cancer Inst 1998;90:766—71.

Kattan M.W., Eastham J.A., Stapleton A.M. et al. A preoperative nomo-gram for disease recurrence following radi-cal prostatectomy for prostate cancer. JNatl Cancer Inst 1998;90:766—71.

24.

24. Stephenson A.J., Scardino P.T.,Eastham J.A. et al. Preoperative nomogrampredicting the 10-year probability ofprostate cancer recurrence after radicalprostatectomy. J Natl Cancer Inst2006;98:715—7.

Stephenson A.J., Scardino P.T.,Eastham J.A. et al. Preoperative nomogrampredicting the 10-year probability ofprostate cancer recurrence after radicalprostatectomy. J Natl Cancer Inst2006;98:715—7.

25.

25. Kattan M.W., Wheeler T.M., Scardino P.T. Postoperative nomogram fordisease recurrence after radical prostatecto-my for prostate cancer. J Clin Oncol1999;17:1499—507.

Kattan M.W., Wheeler T.M., Scardino P.T. Postoperative nomogram fordisease recurrence after radical prostatecto-my for prostate cancer. J Clin Oncol1999;17:1499—507.

26.

26. Stephenson A.J., Scardino P.T.,Eastham J.A. et al. Postoperative nomo-gram predicting the 10-year probability ofprostate cancer recurrence after radicalprostatectomy. J Clin Oncol2005;23:7005—12.

Stephenson A.J., Scardino P.T.,Eastham J.A. et al. Postoperative nomo-gram predicting the 10-year probability ofprostate cancer recurrence after radicalprostatectomy. J Clin Oncol2005;23:7005—12.

27.

27. Snow P.B., Smith D.S., Catalona W.J.Artificial neural networks in the diagnosisand prognosis of prostate cancer: a pilotstudy. J Urol 1994;152:1923—6.

Snow P.B., Smith D.S., Catalona W.J.Artificial neural networks in the diagnosisand prognosis of prostate cancer: a pilotstudy. J Urol 1994;152:1923—6.

28.

28. Pepe M.S., Janes H., Longton G. et al.Limitations of the odds ratio in gauging theperformance of a diagnostic, prognostic, orscreening marker. Am J Epidemiol2004;159:882—90.

Pepe M.S., Janes H., Longton G. et al.Limitations of the odds ratio in gauging theperformance of a diagnostic, prognostic, orscreening marker. Am J Epidemiol2004;159:882—90.

29.

29. Kattan M.W. Judging new markers bytheir ability to improve predictive accuracy.J Natl Cancer Inst 2003;95:634—5.3

Kattan M.W. Judging new markers bytheir ability to improve predictive accuracy.J Natl Cancer Inst 2003;95:634—5.3

30.

0. Bradley E., TibshiraniR.J. Monographs on statistics and appliedprobability: an introduction to the boot-strap. NY: Chapman and Hall/CRC, 1993.p. 275.

Bradley E., TibshiraniR.J. Monographs on statistics and appliedprobability: an introduction to the boot-strap. NY: Chapman and Hall/CRC, 1993.p. 275.

31.

31. Schroder F., Kattan M.W. The compa-rability of models for predicting the risk ofa positive prostate biopsy with prostate-spe-cific antigen. Eur Urol 2008;54(2):274—90.

Schroder F., Kattan M.W. The compa-rability of models for predicting the risk ofa positive prostate biopsy with prostate-spe-cific antigen. Eur Urol 2008;54(2):274—90.